Infliximab does not increase postoperative complication rates in patients with Crohn's disease

被引：0
|
作者：
Marchal, L
D'Haens, G
Van Assche, G
Hiele, M
D'Hoore, A
Penninckx, F
Rutgeerts, P
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)81038-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A207 / A207
页数：1
相关论文
共 50 条
  • [1] Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery
    Kasparek, Michael S.
    Bruckmeier, Andreas
    Beigel, Florian
    Mueller, Mario H.
    Brand, Stephan
    Mansmann, Ulrich
    Jauch, Karl-Walter
    Ochsenkuehn, Thomas
    Kreis, Martin E.
    INFLAMMATORY BOWEL DISEASES, 2012, 18 (07) : 1207 - 1213
  • [2] Biologic Therapy Does Not Increase Postoperative Complication in Crohn's Disease
    Alhamly, Hadeel Z. M.
    Qadhi, Iman N.
    Al-rubaiah, Rawan
    Alabbad, Jasim Y.
    Raheem, Fawaz Abdul
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2023, 237 (05) : S98 - S98
  • [3] Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn's Disease
    Regueiro, Miguel
    El-Hachem, Sandra
    Kip, Kevin E.
    Schraut, Wolfgang
    Baidoo, Leonard
    Watson, Andrew
    Swoger, Jason
    Schwartz, Marc
    Barrie, Arthur
    Pesci, Marilyn
    Binion, David
    DIGESTIVE DISEASES AND SCIENCES, 2011, 56 (12) : 3610 - 3615
  • [4] Postoperative Infliximab Is Not Associated with An Increase in Adverse Events in Crohn’s Disease
    Miguel Regueiro
    Sandra El-Hachem
    Kevin E. Kip
    Wolfgang Schraut
    Leonard Baidoo
    Andrew Watson
    Jason Swoger
    Marc Schwartz
    Arthur Barrie
    Marilyn Pesci
    David Binion
    Digestive Diseases and Sciences, 2011, 56 : 3610 - 3615
  • [5] Infliximab does not increase the risk of complications in the perioperative period in patients with Crohn's disease
    Brzezinski, A
    Armstrong, L
    Del Real, GA
    Parsi, M
    Lashner, B
    Achkar, JP
    GASTROENTEROLOGY, 2002, 122 (04) : A617 - A617
  • [6] Inummosuppression with steroids or azathioprine does not increase the postoperative complication rate in abdominal surgery for Crohn's disease
    Kuper, M
    Dinescu, A
    Mueller, MH
    Meile, T
    Kasparek, M
    Glatzle, J
    Jehle, EC
    Kreis, ME
    Zittel, TT
    GASTROENTEROLOGY, 2004, 126 (04) : A805 - A805
  • [7] Infliximab dosage increase rate in patients with Crohn's disease
    Plevy, Scott
    Wu, Eric
    Yu, Andrew
    Chao, Jingdong
    Mulani, Parvez
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S380 - S380
  • [8] IMMUNOSUPPRESSIVE THERAPY DOES NOT INCREASE POSTOPERATIVE MORBIDITY IN PATIENTS WITH CROHN'S DISEASE.
    Bafford, A.
    Powers, S.
    Ha, C.
    Gorfine, S.
    Chessin, D.
    Bauer, J.
    DISEASES OF THE COLON & RECTUM, 2010, 53 (04) : 605 - 605
  • [9] Pericarditis as a complication of infliximab therapy in Crohn's disease
    Burke, J. P.
    Kelleher, B.
    Ramadan, S.
    Quinlan, M.
    Sugrue, D.
    O'Donovan, M. A.
    INFLAMMATORY BOWEL DISEASES, 2008, 14 (03) : 428 - 429
  • [10] Does a histologically inflamed resection margin increase postoperative complications in patients with Crohn's disease?
    Aaltonen, Gisele
    Ristimaki, Ari
    Keranen, Ilona
    Carpelan-Holmstrom, Monika
    Lepisto, Anna
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2018, 53 (03) : 279 - 283
12345